A detailed history of 1858 Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, 1858 Wealth Management, LLC holds 2,619 shares of VRTX stock, worth $1.07 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
2,619
Previous 2,662 1.62%
Holding current value
$1.07 Million
Previous $1.25 Billion 2.4%
% of portfolio
1.0%
Previous 1.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$460.0 - $505.78 $19,780 - $21,748
-43 Reduced 1.62%
2,619 $1.22 Billion
Q2 2024

Jul 18, 2024

SELL
$392.81 - $485.53 $98,988 - $122,353
-252 Reduced 8.65%
2,662 $1.25 Billion
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $999,502 - $1.2 Million
2,914 New
2,914 $1.19 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track 1858 Wealth Management, LLC Portfolio

Follow 1858 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1858 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1858 Wealth Management, LLC with notifications on news.